New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders.
Qawi
I
I
Robson
S C
SC
D000251:Adenosine Triphosphatases / Q000627:therapeutic use*; D015703:Antigens, CD / Q000627:therapeutic use*; D001081:Apyrase / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D006801:Humans; D050356:Lipid Metabolism; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy*
D015703:Antigens, CD; D010975:Platelet Aggregation Inhibitors; D000251:Adenosine Triphosphatases; D001081:Apyrase; C067869:CD39 antigen